Cargando…

Four‐year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes

AIMS/INTRODUCTION: Despite being the most common complication of diabetes, the pattern of clinical development of diabetic neuropathy is not well‐known. In the present study, we retrospectively examined sequential changes in nerve conduction studies (NCS) for 4 years to characterize the way neuropat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobori, Mariko, Yagihashi, Soroku, Shiina, Norie, Shiozawa, Nana, Haginoya, Akiko, Ojima, Misato, Douguchi, Satako, Tamasawa, Atsuko, Saitou, Miyoko, Baba, Masayuki, Osonoi, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415466/ https://www.ncbi.nlm.nih.gov/pubmed/27736033 http://dx.doi.org/10.1111/jdi.12583

Ejemplares similares

Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia
por: Osonoi, Takeshi, et al.
Publicado: (2023)

Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study
por: Osonoi, Takeshi, et al.
Publicado: (2023)

Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study
por: Osonoi, Takeshi, et al.
Publicado: (2020)

Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial
por: Osonoi, Takeshi, et al.
Publicado: (2023)

Efficacy of ipragliflozin as monotherapy or as add‐on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics
por: Osonoi, Takeshi, et al.
Publicado: (2017)

Canagliflozin Increases Postprandial Total Glucagon-Like Peptide 1 Levels in the Absence of α-Glucosidase Inhibitor Therapy in Patients with Type 2 Diabetes: A Single-Arm, Non-randomized, Open-Label Study
por: Osonoi, Takeshi, et al.
Publicado: (2019)

Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2014)

S100 Genes are Highly Expressed in Peripheral Leukocytes of Type 2 Diabetes Mellitus Patients Treated with Dietary Therapy
por: Kondo, Shinnosuke, et al.
Publicado: (2021)

Relationship between dietary patterns and risk factors for cardiovascular disease in patients with type 2 diabetes mellitus: a cross-sectional study
por: Osonoi, Yusuke, et al.
Publicado: (2016)

Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus
por: Osonoi, Yusuke, et al.
Publicado: (2015)

Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study
por: Ogihara, Takeshi, et al.
Publicado: (2017)

Relationships Among Conventional Cardiovascular Risk Factors and Lifestyle Habits With Arterial Stiffness in Type 2 Diabetic Patients
por: Hamamura, Misako, et al.
Publicado: (2017)

Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese
por: Mizukami, Hiroki, et al.
Publicado: (2014)

Clinical staging of type 2 diabetes: The time has come
por: Yagihashi, Soroku
Publicado: (2012)

Imaging of insulin factory: Is it just imagination or approaching reality?
por: Yagihashi, Soroku
Publicado: (2012)

Diabetes and pancreas size, does it matter?
por: Yagihashi, Soroku
Publicado: (2016)

What can we learn from the islet of Joslin Medalists?
por: Yagihashi, Soroku
Publicado: (2020)

Gut as a source of new β‐cells and Segi's cap
por: Yagihashi, Soroku
Publicado: (2023)

Contribution of animal models to diabetes research: Its history, significance, and translation to humans
por: Yagihashi, Soroku
Publicado: (2023)

The Impact of Low-Dose Insulin on Peripheral Nerve Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats
por: Sugimoto, Kazuhiro, et al.
Publicado: (2013)

Islet microangiopathy and augmented β‐cell loss in Japanese non‐obese type 2 diabetes patients who died of acute myocardial infarction
por: Takahashi, Kazuhisa, et al.
Publicado: (2021)

Increased Oxidative Stress Underlies Abnormal Pain Threshold in a Normoglycemic Japanese Population
por: Osonoi, Sho, et al.
Publicado: (2020)

Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway
por: Mizukami, Hiroki, et al.
Publicado: (2020)

Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation
por: Umetsu, Satoko, et al.
Publicado: (2020)

Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
por: Uchida, Chiaki, et al.
Publicado: (2021)

Exploring a New Therapy for Diabetic Polyneuropathy – The Application of Stem Cell Transplantation
por: Mizukami, Hiroki, et al.
Publicado: (2014)

Expression of Type IV Collagen and Its Degrading Enzymes in Squamous Cell Carcinoma of Lung
por: Nakagawa, Hideyuki, et al.
Publicado: (1994)

Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients
por: Katakami, Naoto, et al.
Publicado: (2014)

Lipopolysaccharide-binding protein is a distinctive biomarker of abnormal pain threshold in the general Japanese population
por: Kudoh, Kazuhiro, et al.
Publicado: (2020)

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double‐blind placebo‐controlled trial
por: Satoh, Jo, et al.
Publicado: (2011)

The Possible Role of Tumor Necrosis Factor-α in Diabetic Polyneuropathy
por: Satoh, Jo, et al.
Publicado: (2003)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Dynamic pathology of islet endocrine cells in type 2 diabetes: β‐Cell growth, death, regeneration and their clinical implications
por: Yagihashi, Soroku, et al.
Publicado: (2015)

Quo vadis: Where have the β-cells gone?
por: Yagihashi, Soroku, et al.
Publicado: (2015)

mRNA expression of delta-HER2 and its clinicopathological correlation in HER2-overexpressing breast cancer
por: Wada, Ryuichi, et al.
Publicado: (2016)

Neuropathy induced by exogenously administered advanced glycation end‐products in rats
por: Nishizawa, Yusuke, et al.
Publicado: (2010)

Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies
por: Sango, Kazunori, et al.
Publicado: (2017)

Impaired nerve fiber regeneration in axotomized peripheral nerves in streptozotocin‐diabetic rats
por: Nishida, Naoki, et al.
Publicado: (2013)

Normal High HbA1c a Risk Factor for Abnormal Pain Threshold in the Japanese Population
por: Itabashi, Chieko, et al.
Publicado: (2019)

Corrigendum: Normal High HbA1c a Risk Factor for Abnormal Pain Threshold in the Japanese Population
por: Itabashi, Chieko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_10m30a3bqvgcdae1ssls8hc3o7